Finished Dosage Manufacturing

MSN Group Finished Dosage Manufacturing campus manufactures and supplies commercial finished dosages to Novadoz. Product manufacturing capabilities include oral solids, injectables (general & oncolytic), and liquids. The facility provides manufacturing, Q/A Q/C research & lab testing, and stability validation services. The total manufacturing space is over 350,000 sq. ft. with 90,000 of it completed offering ample room for growth.  The facilities are located in close proximity to Hyderabad International Airport, to facilitate efficient logistics.  MSN’s finished dosage facilities have been successfully audited 5 times since 2016 without any major 483 observations.

The facility is equipped for the manufacturing of complex generic products. The temperature-controlled facility is compatible to fulfil operations under sub-zero environment.  High-speed bulk and blister packing lines ensure speed and flexibility in supply. Our warehousing facilities contain refrigeration units and are ambient temperature controlled. The facilities are compliant with DSCSA serialization regulations.  Our logistic services are performed in VAWD accredited distribution centers and we place a strong value in performing customer service at the highest level.

In addition to our vast manufacturing capabilities in India, the company has acquired a 200,000 sq. ft. manufacturing facility in the U.S located in Piscataway, New Jersey.  This facility will be manufacturing oral solids, injectables, and liquids and will be operational by the end of 2018.

« Back To Home Page

Finished Dosage Manufacturing